Efficacy of Xingpi Huazhuo Prescription in treating pre-diabetic patients with phlegm-dampness constitution and its influences on blood glucose and renal function indexes

LI Lijuan; WU Jie; SHANG Xinxiu; FENG Weixun

doi:10.7619/jcmp.20242530

Journal of Clinical Medicine in Practice > 2025 > 29(4): 60-63. > DOI: 10.7619/jcmp.20242530

LI Lijuan, WU Jie, SHANG Xinxiu, FENG Weixun. Efficacy of Xingpi Huazhuo Prescription in treating pre-diabetic patients with phlegm-dampness constitution and its influences on blood glucose and renal function indexes[J]. Journal of Clinical Medicine in Practice, 2025, 29(4): 60-63. DOI: 10.7619/jcmp.20242530

Citation:

PDF (625 KB)

Efficacy of Xingpi Huazhuo Prescription in treating pre-diabetic patients with phlegm-dampness constitution and its influences on blood glucose and renal function indexes

1.
Department of Endocrinology, Shijiazhuang Hospital of Traditional Chinese Medicine, Shijiazhuang, Hebei, 050000
2.
Department of Endocrinology, Hebei Hospital of Traditional Chinese Medicine, Shijiazhuang, Hebei, 050000
3.
Department of Nephrology, Dingzhou People's Hospital of Hebei Province, Dingzhou, Hebei, 073000

More Information

Received Date: June 13, 2024
Revised Date: August 23, 2024

Graphical Abstract

Abstract

Abstract

Objective
To investigate the efficacy of Xingpi Huazhuo Prescription in treating pre-diabetic patients with phlegm-damp constitution and its impacts on blood glucose levels and renal function indicators.
Methods
A total of 104 pre-diabetic patients with phlegm-damp constitution admitted to the hospital between January 2021 and December 2023 were selected and randomly divided into western medicine group (n=52) and combined group (n=52) using a random number table method. The western medicine group received metformin treatment, while the combined group received metformin combined with Xingpi Huazhuo Prescription. Clinical efficacy was recorded after 3 months of treatment, and blood glucose indexes such as [fasting blood glucose (FPG), glycated hemoglobin (HbA1c), and 2-h plasma glucose (2 hPG)] levels, lipid indicators[triglycerides (TG), total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C)], and renal function indicators [serum creatinine (Scr), urea nitrogen (BUN), β₂-microglobulin (β₂-MG)] were compared before and after 3 months of treatment.
Results
After 3 months of treatment, the total clinical effectiveness in the combined group was higher than that in the western medicine group (P < 0.05). After 3 months of treatment, the levels of FPG, HbA1c, and 2 hPG decreased in both groups, and the combined group showed lower levels than the western medicine group (P < 0.05). After 3 months of treatment, the levels of TG, TC, and LDL-C decreased in both groups compared with before treatment, and the combined group showed lower levels than the western medicine group (P < 0.05); the levels of HDL-C increased in both groups, and the combined group showed higher levels than the western medicine group (P < 0.05). After 3 months of treatment, the levels of Scr, BUN, and β₂-MG decreased in both groups, with the combined group showing lower levels than the western medicine group (P < 0.05).
Conclusion
In pre-diabetic patients with phlegm-damp constitution, metformin combined with Xingpi Huazhuo Prescription can effectively improve blood glucose levels and exert renal protective effects.
- pre-diabetes,
- Xingpi Huazhuo Prescription,
- phlegm-damp constitution,
- blood glucose,
- renal function,
- blood lipid

FullText(HTML)

References (16)

References

[1]	LUO X J, WANG Z Z, LI B W, et al. Effect of resistance vs. aerobic exercise in pre-diabetes: an RCT[J]. Trials, 2023, 24(1): 110. doi: 10.1186/s13063-023-07116-3
[2]	陈怡, 彭年春, 张淼, 等. 贵阳城区40岁及以上不同亚型糖尿病前期人群10年心血管疾病发生风险的队列研究[J]. 中华内分泌代谢杂志, 2024, 40(5): 373-379.
[3]	李玲, 朱磊, 侯稳, 等. 糖尿病前期脑出血患者的临床特征及预后分析[J]. 实用临床医药杂志, 2023, 27(5): 119-122, 127. doi: 10.7619/jcmp.20223485
[4]	张祯, 李克明, 徐鑫. 桃仁承气汤化裁联合西医序贯治疗2型糖尿病患者的效果[J]. 实用临床医药杂志, 2023, 27(20): 122-126. doi: 10.7619/jcmp.20232251
[5]	高彦彬, 倪青, 徐云生, 等. 糖尿病前期(脾瘅)中医诊疗优化方案(2023版)[J]. 世界中西医结合杂志, 2023, 18(5): 1046-1050.
[6]	中华医学会内分泌学分会, 中华医学会糖尿病学分会, 中国医师协会内分泌代谢科医师分会, 等. 中国成人糖尿病前期干预的专家共识[J]. 中华内分泌代谢杂志, 2020, 36(5): 371-380.
[7]	中华中医药学会糖尿病分会. 糖尿病前期中医诊疗标准[J]. 世界中西医结合杂志, 2011, 6(5): 446-449.
[8]	中华中医药学会. 糖尿病中医防治指南[M]. 北京: 中国中医药出版社, 2007: 1-3.
[9]	赵加, 王倩, 苑浩彬, 等. 六君子汤加味穴位贴敷治疗脾虚痰湿型糖尿病前期肥胖患者的疗效及对患者炎症因子和肠道菌群的影响[J]. 河北中医, 2023, 45(7): 1150-1155.
[10]	张慧芬, 周宇清, 吴倩莹, 等. 黄芪消积化浊汤治疗糖尿病前期脾虚痰湿证患者的疗效及安全性研究[J]. 中医药导报, 2023, 29(12): 53-56, 83.
[11]	WANG S, DU S S, WANG W Z, et al. Therapeutic investigation of quercetin nanomedicine in a zebrafish model of diabetic retinopathy[J]. Biomedecine Pharmacother, 2020, 130: 110573.
[12]	JIA W J, BI Q M, JIANG S R, et al. Hypoglycemic activity of Codonopsis pilosula (Franch. ) Nannf. In vitro and in vivo and its chemical composition identification by UPLC-Triple-TOF-MS/MS[J]. Food Funct, 2022, 13(5): 2456-2464.
[13]	金丽霞, 张雨晴, 金丽军, 等. 加味参芪地黄汤联合穴位注射治疗气阴两虚血瘀型Ⅲ~Ⅳ期糖尿病肾病临床观察[J]. 现代中西医结合杂志, 2023, 32(24): 3422-3426.
[14]	WANG X J, ZHOU W E, WANG Q, et al. A novel and comprehensive strategy for quality control in complex Chinese medicine formula using UHPLC-Q-Orbitrap HRMS and UHPLC-MS/MS combined with network pharmacology analysis: take Tangshen formula as an example[J]. J Chromatogr B Analyt Technol Biomed Life Sci, 2021, 1183: 122889.
[15]	冯静, 李玲玲, 崔瑛. 茯苓对阴虚水肿模型大鼠及其热象的影响[J]. 中草药, 2023, 54(2): 586-592.
[16]	魏蜀吴, 孙卫卫, 姜伟民, 等. 痰湿与2型糖尿病脂代谢紊乱的相关性临床研究[J]. 浙江中医药大学学报, 2022, 46(10): 1136-1140.

[1]	YAO Binbin, SHEN Yan, YANG Hongli, FENG Sujuan, HUANG Huaxing, ZHU Xueling, SHEN Lianglan. Impact of serum cystatin C and hypersensitivity C-reactive protein on the 3-year survival of patients undergoing maintenance hemodialysis[J]. Journal of Clinical Medicine in Practice, 2024, 28(18): 68-75, 80. DOI: 10.7619/jcmp.20240283
[2]	QIU Yuan, LI Li, ZENG Laixing. Changes of C reactive protein and serum procalcitoninin patients with severe acute pancreatitis[J]. Journal of Clinical Medicine in Practice, 2019, 23(12): 62-64. DOI: 10.7619/jcmp.201912018
[3]	MENG Xiangzhong, WEI Feng, WANG Na, SHI Zhenhua, DING Dongrui. Clinical analysis of plasma procalcitonin and C-reactive protein levels in 65 patients with septic shock[J]. Journal of Clinical Medicine in Practice, 2018, (3): 120-122. DOI: 10.7619/jcmp.201803035
[4]	LIU Li, LIU Mingxin, NIU Shihui, LU Zejun, WANG Nana, ZHANG Ling. Effect of irbesartan combined with atorvastatin on C reactive protein and cystatin C of patients with diabetic nephropathy[J]. Journal of Clinical Medicine in Practice, 2017, (21): 33-35. DOI: 10.7619/jcmp.201721009
[5]	ZHANG Shihui, ZHANG Yan, TANG Xi. Effects of hemodialysis combined with hemoperfusion on expression of β2-microglobulin and high-sensitivity C-reactive protein in patients with uremia[J]. Journal of Clinical Medicine in Practice, 2017, (5): 65-67. DOI: 10.7619/jcmp.201705018
[6]	LI Zhi. Changes and diagnostic value of serum procalcitonin and C-reactive protein in patients with severe infection in ICU[J]. Journal of Clinical Medicine in Practice, 2016, (5): 70-72. DOI: 10.7619/jcmp.201605021
[7]	LIU Chijia, CUI Yuntao, ZHANG Aimin. Change and significance of serum procalcitonin and C-reactive protein levels in cerebral hemorrhage patients complicated with infection[J]. Journal of Clinical Medicine in Practice, 2015, (13): 27-29. DOI: 10.7619/jcmp.201513008
[8]	XU Bin, FAN Zhigang, YANG Yun, XU Zongxian. Application of serum procalcitonin and C-reactive protein detections in the diagnosis of neonatal severe infectious disease[J]. Journal of Clinical Medicine in Practice, 2014, (24): 50-52. DOI: 10.7619/jcmp.201424015
[9]	YU Yanhua, LI Junrong, HOU Zhuoran. Influence of atorvastatin on serum visfatin,high-sensitivity C-reactive protein and nitric oxide in patients with acute cerebral infarction[J]. Journal of Clinical Medicine in Practice, 2014, (23): 5-7. DOI: 10.7619/jcmp.201423002
[10]	ZHOU Lihua. Clinical significance of C-reactive protein and immunoglobulin in cerebrospinal fluid for children infected with meningitis[J]. Journal of Clinical Medicine in Practice, 2013, (16): 123-124,130. DOI: 10.7619/jcmp.201316048

Cited By

Cited by

Periodical cited type(2)

1.	于琪力，葛雪，刘丽. 冠状动脉粥样硬化性心脏病患者心力衰竭危险因素分析. 新乡医学院学报. 2024(06): 560-565 .
2.	孙宁，李飞. 心肌梗死患者血清miR-34a-5p和C1q/肿瘤坏死因子相关蛋白-9水平及其与心肌重构的相关性. 检验医学与临床. 2024(19): 2785-2789 .

Other cited types(0)

Get Citation

PDF

XML

Article views PDF downloads Cited by(2)

Turn off MathJax

Article Contents

Abstract

References

Efficacy of Xingpi Huazhuo Prescription in treating pre-diabetic patients with phlegm-dampness constitution and its influences on blood glucose and renal function indexes

Abstract

References

Related Articles

Cited by

Periodical cited type(2)

Other cited types(0)

Catalog

Efficacy of Xingpi Huazhuo Prescription in treating pre-diabetic patients with phlegm-dampness constitution and its influences on blood glucose and renal function indexes

Abstract

References

Related Articles

Cited by

Periodical cited type(2)

Other cited types(0)

Catalog

Export File

Citation

Format

Content